Table 3.
Perioperative parameters and clinical events in patients with and without late deterioration in renal function and univariate regression analysis for prediction of late deterioration in renal function.
with LDRF (n = 14) | without LDRF (n = 55) | p value | Odds ratio | 95% CI | p value | |
---|---|---|---|---|---|---|
LVAD implantation - discharge | ||||||
perioperative AKI (%) | 57.1 | 16.4 | 0.0028* | 6.8 | 1.90–24.43 | 0.0032* |
Alb (mg/dL)(1) | 3.1 ± 0.5 | 3.2 ± 0.4 | 0.23 | 0.12 | 0.0035–3.89 | 0.22 |
eGFR (mL/min/1.73 m2) (1) | 108.7 ± 45.8 | 96.4 ± 27.5 | 0.20 | 5.9 | 0.38–93.11 | 0.20 |
T-bil (mg/dL)(1) | 0.9 ± 0.2 | 0.8 ± 0.2 | 0.29 | 4.4 | 0.28–69.48 | 0.30 |
BNP (pg/mL)(1) | 310.4 [ 177.9–732.0] | 236.9 [143.2–395.9] | 0.23 | 11.3 | 0.76–168.65 | 0.079 |
RAP (mmHg)(1) | 9.4 ± 4.4 | 7.8 ± 3.9 | 0.20 | 4.9 | 0.43–55.79 | 0.20 |
PAWP (mmHg)(1) | 10.1 ± 5.7 | 8.4 ± 4.9 | 0.27 | 3.8 | 0.34–43.75 | 0.28 |
Cardiac Index (L/min/m2)(1) | 2.5 ± 0.8 | 2.5 ± 0.5 | 0.94 | 0.8 | 0.025–31.36 | 0.94 |
RVSWI (g·m/m2/beat)(1) | 3.6 ± 3.4 | 4.0 ± 1.8 | 0.61 | 0.4 | 0.0082–16.3 | 0.60 |
PAPi(1) | 2.1 ± 1.4 | 2.1 ± 1.5 | 0.86 | 0.7 | 0.013–35.97 | 0.86 |
Aortic valve opening (%)(1) | 50.0 | 34.5 | 0.29 | 1.9 | 0.58–6.2 | 0.29 |
Events from discharge to 30 months after LVAD implantation | ||||||
AKI (%)(2) | 35.7 | 23.6 | 0.37 | 1.8 | 0.51–6.31 | 0.36 |
Pump thrombosis (%)(2) | 14.3 | 12.7 | 0.88 | 1.1 | 0.21–6.22 | 0.88 |
AI (%)(2) | 57.1 | 18.9 | 0.0061* | 5.7 | 1.62–20.26 | 0.0061* |
DLI (%)(2) | 28.6 | 43.6 | 0.30 | 0.52 | 0.14–1.85 | 0.31 |
Stroke (%)(2) | 7.1 | 23.6 | 0.13 | 0.25 | 0.030–2.08 | 0.13 |
VA (%)(2) | 57.1 | 21.8 | 0.012* | 4.8 | 1.39–16.46 | 0.013* |
late RVF (%)(2) | 35.7 | 0 | <0.0001* | 6.7 × 107 | n/a | <0.0001* |
RAASi at 30 months (%) | 42.8 | 60 | 0.25 | 0.5 | 0.15–1.64 | 0.25 |
*: Significantly different between with and without LDRF
(1): result at 1 month after LVAD implantation
(2): the incidence of each adverse event after discharge from hospital following the index LVAD implantation up to 30 months
(3): the degree of AI could not be estimated in two patients due to poor study.
LVAD; left ventricular assist device, LDRF; late deterioration in renal function, CI: confidence interval, AKI; acute kidney injury, Alb; albumin, T-bil; total-bilirubin, BNP; brain natriuretic peptide, RAP; right atrial pressure, PAWP; pulmonary artery wedge pressure, RVSWI; right ventricular stroke work index, PAPi; pulmonary artery pulsatility index, RAASi; renin-angiotensin-aldosterone system inhibitor, AI; aortic insufficiently, DLI; driveline infection, VA; ventricular arrhythmia, RVF; right ventricular failure